Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine for emergence agitation after minor surgery in children
ChiCTR2500098410Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Zhengzhou University
- Start
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in Emergence agitation (EA), postoperative behavioral disturbance (PBD) and postoperative pain (2 arms), sponsored by The First Affiliated Hospital of Zhengzhou University. Primary endpoints: Postoperative behavioral change score (PHBQ), Pain score and 1 more. Planned start Mar 2025; status: not yet recruiting.
02
Drugs
esketamine
03
Conditions
Emergence agitation (EA)postoperative behavioral disturbance (PBD)postoperative pain
Beyond the preview
Go deeper on ChiCTR2500098410.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500098410.